US Stocks Rally on Tech Gains and Fed Rate Cut Hopes | The Close 11/24/2025

Here's a comprehensive summary of the provided YouTube video transcript:

Key Concepts

• Market Performance: S&P 500 gains, Nasdaq 100 rally, Mag-7 leadership, Tesla's surge, Bitcoin's volatility and recovery.
• Economic Data & Fed Policy: September U.S. Retail Sales, Producer Price Index (PPI), Durable Goods Orders, Federal Reserve (Fed) rate cut expectations, Fed Governor Christopher Waller's comments, market pricing for December rate cut.
• Investment Strategy & Outlook: 2025 as a "soft patch," 2026 as a better year, headwinds (tariffs, tax policy, inflation), labor market trends, equity vs. fixed income allocation, private markets (private equity, private credit), cash demand, broadening market participation.
• Bitcoin & Crypto: Correlation with President Trump's approval rating, legislative efforts (Clarity Act, Genius Act), tokenization of stablecoins, Bitcoin as a measure of risk appetite.
• Healthcare Sector: Merck's upgrade, Novo Nordisk's Ozempic pill failure for Alzheimer's, Eli Lilly's prospects, patent cliffs, innovation in pharma.
• AI & Technology: Alphabet's Gemini 3 chatbot, comparison with ChatGPT, Apple's potential LLM partnership, AI spending and its tangible value, agentic AI, job cuts due to AI, skills gap.
• Retail Sector: Kohl's CEO promotion, technological debt, tariffs, Dick's Sporting Goods acquisition, Abercrombie & Fitch's performance, U.S. consumer sentiment.
• Economic Data Analysis: Impact of government shutdown on data release, backward-looking nature of delayed reports, affordability squeeze, policy interventions.
• Travel Industry: Home swapping as an alternative to hotels/Airbnb, Kindred's business model, affordability as a top consumer concern.

Market Performance and Economic Outlook

1. U.S. Financial Markets Overview: The S&P 500 opened higher and continued to climb, marking its second consecutive day of gains with a 1.4% increase. The "Mag-7" stocks led the rally, up 3.5%, with Tesla at the forefront. Yields across the curve were lower, indicating a range-bound market ahead of the FOMC meeting on December 10th. Bitcoin also saw gains, trading in the green at 0.4%, after falling below $86,000 earlier in the day following a volatile weekend. Wall Street's optimism in tech is translating into a broader risk-on appetite, even boosting Bitcoin. Traders appear to be overlooking recent volatility and AI valuation concerns, with Aztec leading today's rally and sending the Nasdaq 100 up over 2%.

2. Analyst Perspectives on Market Pullbacks: Michael Wilson of Morgan Stanley joined the chorus of "bulls," suggesting the recent pullback is ending and presenting a buying opportunity into the new year. However, he noted that AI jitters mean the S&P 500 is unlikely to hit his year-end target of 7,000, but it could reach that mark next year. He described the current situation as "the air is coming out of the bubble rather than the bubble bursting," which he considers a positive development.

3. Key Economic Data Releases: Traders are awaiting crucial consumer data, including September U.S. Retail Sales, due tomorrow. The Producer Price Index (PPI) and Durable Goods Orders are also scheduled for release later in the week, which could significantly influence the Federal Reserve's decisions.

4. Federal Reserve Rate Cut Expectations: Money markets are pricing in favorable odds for a Fed rate cut at its next meeting. Fed Governor Christopher Waller fueled optimism by indicating support for a cut next month. Market pricing for a December rate cut has shifted significantly since the Fed's last meeting in late October. Throughout November, hopes for a cut were fading, with market pricing moving upwards. This changed after the meeting minutes revealed a preference for steady rates and a subsequent "stale" jobs report renewed concerns about the labor market. In the last two days, dovish comments from Waller and New York Fed President Williams have led to a quick shift, with almost a full 25 basis point cut now priced in.

5. Expert Interview: Jim Caron, CIO of Portfolio Solutions Group at Morgan Stanley Investment Management:

• Fed Meeting Uncertainty: Caron emphasized the market's lack of clarity on the December Fed meeting, stating the probability of a 25 basis point cut has swung from 30% to 70% in a week, but he believes it's a 50-50 call.
• 2025 vs. 2026 Outlook: He anticipates 2026 will be a better year, with 2025 being a "soft patch." While economic data slowed as expected, it was masked by equities making new all-time highs. He expects a recovery in data in 2026, forming the "right side of the U" for economic recovery.
• Drivers for 2026 Improvement: Caron cited the absence of tariffs, clearer tax policy, and moderating inflation as key tailwinds. He also anticipates an onslaught of fiscal stimulus, including accelerated depreciation and tax rebates for consumers.
• Labor Market Forecast: He expects the labor market to weaken before strengthening. While the official unemployment rate is 4.4%, he believes the real number is closer to 4.8-4.9%. He anticipates a soft patch in jobs, particularly in Q1 2026, followed by a recovery and stabilization, especially for mid and small-cap companies which drive 70% of job hiring.
• Asset Allocation: Morgan Stanley remains overweight equities over fixed income, as fixed income spreads are tight and rates have come down, with Fed Funds priced in around 3.5%. Equities are seen as having the most upside potential, with expectations for a broadening market beyond the Mag-7.
• Private Markets: Private markets are still interesting but experiencing "fits and starts." Private credit is undergoing repricing and reunderwriting. Private equity is seen as having reached the bottom, but patience is required for returns. He believes private equity currently looks more attractive than private credit due to past valuation concerns being in the past, while worries persist in private credit.
• Public Credit Markets: No evidence of spillover into public credit markets. Default risks are expected to remain low in 2026, with tight spreads indicating yield buyers. While further spread tightening is unlikely, clipping the coupon with reasonable confidence is expected.
• Cash Demand: The insatiable demand for cash, with money market funds at $7.5 trillion, is driven by market fragility and narrow leadership. Investors are allocating away from this fragility. A catalyst for investors to move off the sidelines would be a broadening of the market beyond just a few stocks, allowing for diversification into sectors like healthcare, industrials, and materials.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some to pull back and question the market's depth.

3. "Trump Put" and Tokenization: There's speculation about a "Trump put" and what might trigger it. The Clarity Act needs Senate pickup in Q1. The strategic reserve concept for Bitcoin has also stalled, possibly due to funding issues and concerns about debt issuance for a digital asset. Tokenization of stablecoins is ongoing, with banks and financial systems exploring it.

4. Bitcoin as a Risk Appetite Proxy: Bitcoin is considered a pure measure of risk appetite. Its sensitivity to Fed policy and liquidity concerns makes it a proxy for risk. Dovish comments from Fed speakers have historically led to Bitcoin bounces, indicating a "risk pulse waiting to be unleashed" with dip buyers looking for macro support.

Healthcare Sector Analysis

1. Top Calls and Sector Movers:

• Booking Holdings: Upgraded to "Buy" from "Neutral" by Bank of America, with analysts calling AI-related risks "overdone" and maintaining a $6,000 price target. Shares were up 2%.
• Carvana: Wedbush recommends taking advantage of weakness, raising the price target to $400 from $380, with limited downside. Shares were up over 7%.
• Morgan Stanley: Wolf Research raised its rating to "Outperform" from "Peer Perform" with a street-high price target of $98, citing a better revenue outlook and best-in-class growth. Shares were up 3%.

2. Merck: Gained on an upgrade from Wells Fargo to "Overweight," driven by optimism for its business beyond its flagship cancer drug.

3. Novo Nordisk: Shares fell after studies showed its Ozempic pill was not effective in slowing Alzheimer's disease progression.

4. Eli Lilly: Luis, covering Eli Lilly, stated that the company decided years ago not to pursue GLP-1s for Alzheimer's, which appears to have been the right move. Momentum for Eli Lilly continues with upcoming data readouts and the launch of an oral obesity drug with Medicare coverage. The oral pill is considered a significant catalyst for 2026, with potential for another high-efficacy obesity drug. Eli Lilly is not in the boat of companies facing patent cliffs and is considered structurally sound with strong momentum.

5. Merck's Future Prospects: Despite a patent cliff looming for over 50% of its sales, Merck is expected to offset this with current products and its pipeline. The street has not yet fully priced this in, and Merck is expected to be a top performer in the healthcare sector once it rerates.

6. Pharma Sector Performance: The pharma sector is up 19% year-to-date, outperforming the broader market. This is attributed to a new wave of innovation and companies focusing on cures. Political headwinds are seen as more than priced in, with potential upside risk.

AI and Technology Developments

1. Alphabet's Gemini 3 Chatbot: Alphabet's shares surged due to positive reviews for its new AI model, Gemini 3. Users find it seamless with Google's ecosystem, capable of complex and long-form questions. It is not seen as cannibalizing Google Search.

2. Gemini 3 vs. ChatGPT: While ChatGPT may still offer better answers for general text-based searches, Gemini 3 shines in holistic capabilities, including visual reasoning. Google's real-time search index is a key differentiator. OpenAI needs to constantly train models or rely on Bing for real-time search.

3. Apple's AI Strategy: Apple does not have its own LLM. Following Google's monopoly hearing settlement, it's likely Apple will use Google as its default LLM, as it already does for search. While Apple has an integration with OpenAI, it's not native. There's speculation about whether Apple might pay Google for Gemini integration.

4. AI Spending and Tangible Value: There's significant investment in AI infrastructure, with trillions of dollars spent. However, the tangible value is expected to emerge in the application layer, particularly with "agentic AI" delivering value to businesses and consumers. Forethought Technologies develops AI agents for customer experience and customer service, reporting billions in ROI for clients through lower costs, faster resolutions, and improved retention.

5. AI Agents vs. Traditional Chatbots: Modern AI agents, unlike older rule-based chatbots, leverage large language models for intelligence, reasoning, planning, and action. They can go beyond answering questions to performing tasks like issuing refunds or troubleshooting databases.

6. AI and the Workforce: AI is cited for 48,000 job cuts in the U.S. this year. There's a concern about a potential labor shortage and a skills mismatch, particularly a lack of analytical thinkers with strong math abilities. AI is seen as a tool to enhance productivity, but users need to possess quantitative and analytical skills to effectively work with it and identify its limitations or inaccuracies. A decline in critical thinking and math skills among students is a concern for the future workforce, potentially leading to a "hollowing out" of talent for higher positions.

Bitcoin and Cryptocurrency Trends

1. Bitcoin's Volatility and Correlation with Trump: A Bloomberg report highlighted a connection between Bitcoin trading and President Trump's approval rating. This correlation is attributed to sentiment regarding the administration's potential impact on the industry. A risk-off tone and a more hawkish Fed were already weighing on the market, and stalling legislation reduced the tailwind from the Trump administration's efforts to legitimize the asset class. Bitcoin has seen a run since Trump's election, and recent price action has led to questions about market depth and potential drawdowns.

2. Legislative Efforts and Crypto-Friendliness: The Trump administration was perceived as crypto-friendly. The Clarity Act, which passed the House in July, aimed to provide classifications for tokens and coins and clarify regulatory oversight, potentially legitimizing crypto as an asset class. However, recent price action has caused some